Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
CNS Drugs|December 6, 2022
Leveraging Molecular and Immune-Based Therapies in Leptomeningeal MetastasesJessica A Wilcox, Adrienne A BoireWorld Neurosurgery|July 28, 2018
Immunotherapy in GlioblastomaJessica A Wilcox, Rohan Ramakrishna, Rajiv MaggeCurrent Pain and Headache Reports|October 24, 2023
The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management GuidelinesJessica A Wilcox, Rachel Estrera, Adrienne BoireCurrent Neurology and Neuroscience Reports|March 18, 2025
Leptomeningeal Disease: Current Approaches and Future DirectionsUgur Sener, Jessica A Wilcox, Adrienne A BoireBlood|August 28, 2024
How I treat acute venous thromboembolism in patients with brain tumorsAvi Leader, Jessica A Wilcox, Jeffrey I ZwickerNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 5, 2022
Leptomeningeal Metastases: New Opportunities in the Modern EraJessica A Wilcox, Min Jun Li, Adrienne A BoireCurrent Oncology Reports|June 8, 2018
The Utility of Liquid Biopsy in Central Nervous System MalignanciesKathryn S Nevel, Jessica A Wilcox, Lindsay J Robell, et al.Neuro-Oncology Advances|December 19, 2022
A multidisciplinary management algorithm for brain metastasesAlexander Ramos, Alexandra Giantini-Larsen, Susan C Pannullo, et al.Medrxiv : the Preprint Server for Health Sciences|September 30, 2020
Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathyJan Remsik, Jessica A Wilcox, N Esther Babady, et al.Cancer Cell|January 28, 2021
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer PatientsJan Remsik, Jessica A Wilcox, N Esther Babady, et al.Pageof 3